The ruling mandates that the FDA, which initially proposed a release timeline of approximately 23.5 years, must now disclose all relevant documents by mid-2025.
"These extremists dare claim to be for life, but instead of acting to save lives from gun violence, extremists state by state made it legal to open carry a gun without even a permit or background checks," Harris stated.
Comer responded: "It’s clear from the FBI’s response that the unclassified record the Oversight Committee subpoenaed exists, but they are refusing to provide it to the Committee."
The FDA analysts also raised concerns about whether women with medical conditions that should preclude them from taking the pill, primarily breast cancer and undiagnosed vaginal bleeding, would avoid the product.
